SCHEMBL9989146

SCHEMBL9989146

COc1ccc(C(=O)c2ccc(Cl)nc2Cl)cc1.O=C(O)c1ccc(Cl)nc1Cl.O=C(O)c1cnc(Cl)cc1Cl

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.51
RAB9A P51151 1/20 0.51
HTT P42858 4/20 0.46
NPSR1 Q6W5P4 3/20 0.46
MAPK1 P28482 3/20 0.46
GAA P10253 1/20 0.46
LTC4S Q16873 2/20 0.45
KMT2A Q03164 3/20 0.44
NPC1 O15118 1/20 0.42
ALDH1A1 P00352 5/20 0.41
HPGD P15428 3/20 0.41
CYP1A2 P05177 2/20 0.41
CYP2D6 P10635 2/20 0.41
CYP2C19 P33261 2/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2C9 P11712 1/20 0.41
MEN1 O00255 2/20 0.41
PKM P14618 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2218147 0.83 MAPT (0.62) MAPTRAB9AHTTNPSR1MAPK1
SCHEMBL2216311 0.83 MAPT (0.57) MAPTRAB9AHTTNPSR1MAPK1
SCHEMBL1443468 0.71 MAPT (0.63) MAPTRAB9AHTTNPSR1MAPK1
SCHEMBL9726804 0.71 MAPT (0.82) MAPTRAB9AHTTNPSR1MAPK1
SCHEMBL3840933 0.71 MAPT (0.55) MAPTRAB9AHTTNPSR1MAPK1
SCHEMBL29446081 0.71 SMN1; SMN2 (0.47) KMT2AALDH1A1MEN1TP53LMNA
SCHEMBL625580 0.71 SMN1; SMN2 (0.47) KMT2AALDH1A1MEN1TP53LMNA
SCHEMBL15067437 0.70 RXFP1 (0.65) MAPTRAB9AHTTNPSR1MAPK1
Dimethylamine SCHEMBL31596354 0.69 SMN1; SMN2 (0.44) MAPK1GAAKMT2AALDH1A1HPGD
SCHEMBL4841244 0.69 MAPT (0.73) MAPTRAB9AHTTNPSR1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110312992-A1 Inhibitors of C-Kit and Uses Thereof BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM 2011-12-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110312992-A1 Inhibitors of C-Kit and Uses Thereof KIT, CHUK, MASTL MAPT 4194/4885RAB9A 1780/4885HTT 3669/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.